ArticleRNA biology2025
Snhg12 targets miR-199a-5p to regulate osteogenic differentiation of TDSCs via the Fzd4/Wnt/β-catenin pathway.
Article in RNA biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Tendon stem/progenitor cells in heterotopic ossification: functional regulation, molecular mechanisms and targeted therapeutic strategies.Journal of orthopaedic translation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heterotopic ossification (HO) is the formation of bone tissue outside the normal skeletal structure following musculoskeletal injury. Long non-coding RNAs (lncRNAs) play a regulatory role in guiding stem cell differentiation towards osteogenic lineages. Through lncRNA sequencing in this study, we observed an up-regulation of small nucleolar RNA host gene 12 (Snhg12) in HO tissues. The precise function of Snhg12 in the process of tendon stem cells (TDSCs) osteogenic differentiation remains uncertain. Our findings suggest that Snhg12 overexpression exacerbated HO, whereas its suppression ameliorated HO. The lncRNA Snhg12 directly targeted miR-199a-5p to alleviate the suppression of Fzd4 caused by miR-199a-5p. Functionally, experiments conducted in vitro and in vivo demonstrated that HO formation was inhibited by the down-regulation of Fzd4 through the up-regulation of miR-199a-5p. In rescue experiments conducted in vitro, the inhibition of miR-199a-5p or overexpression of Fzd4 reversed the improvement in HO caused by Snhg12 knockdown, and Fzd4 regulated the process of osteogenic differentiation in TDSCs by the Wnt/β-catenin pathway. Taken together, these results demonstrate that Snhg12 modulates HO formation via the Snhg12-miR-199a-5p-Fzd4/Wnt/β-catenin signalling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.